Tucked next to Lululemon and Sephora stores on the main thoroughfare in Hoboken, New Jersey, one of The Joint’s 666 locations across the U.S. serves as a refuge to customers aching from 20 months of working from home slouched on their living room couches peering into laptop screens. Its storefront advertises a “Back Friday” sale—buy 10 chiropractic adjustments, get two free—and advertises a $29 new patient special.
The Joint doesn’t take appointments and doesn’t accept insurance, charging a flat fee of $39 for a single visit and $69 for a subscription that includes four adjustments per month. In 2020, the chain performed 8.3 million adjustments on patients generating $260 million in system-wide sales. Total revenues, including franchise fees, to The Joint will amount to less than $100 million in 2021, so it’s no surprise that its lofty $1.3 billion market cap has attracted short-sellers.
One of those disruptors that has played an outsized role in the global recovery from Covid-19 is Retractable Technologies Inc., a syringe and needle manufacturer based in the Dallas suburb of Little Elm, Texas, which is in the top five of our list for the second year. Founder and CEO Thomas Shaw, trained as a mechanical engineer, began work on designing safer syringes after he saw a news segment in 1989 about a doctor who had contracted HIV from an accidental needlestick.
Shaw, who has never sold a single share of Retractable’s stock, owns a 43% stake in the company worth $130 million and still thinks it’s underappreciated compared with industry heavyweights like Becton Dickinson and Medtronic.
To all those Bitcoiner’s working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick with her lisamiaBTC Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success.